We are live on
!
Find out more
Axa Portfolio holdings
AUM
$256M
1-Year Est. Return
25.01%
This Fund
S&P 500
This Quarter
Est. Return
+8.81%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$30.1B
AUM Growth
+$1.02B
(+3.5%)
Cap. Flow
-$1.16B
Cap. Flow
% of AUM
-3.87%
Top 10 Holdings %
Top 10 Hldgs %
22.79%
Holding
1,200
New
104
Increased
364
Reduced
497
Closed
122
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$50.1M |
| 2 |
Cisco
CSCO
|
+$39.1M |
| 3 |
Edwards Lifesciences
EW
|
+$38.9M |
| 4 |
Eaton
ETN
|
+$37.7M |
| 5 |
Bank of America
BAC
|
+$36.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$92.9M |
| 2 |
Texas Instruments
TXN
|
+$67.4M |
| 3 |
Pfizer
PFE
|
+$57.7M |
| 4 |
Fidelity National Information Services
FIS
|
+$56.9M |
| 5 |
Tesla
TSLA
|
+$51.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.71% |
| 2 | Healthcare | 19.22% |
| 3 | Consumer Discretionary | 11.86% |
| 4 | Financials | 8.66% |
| 5 | Industrials | 8.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
MSCI
MSCI
$42.4B
| $74.7M | 0.25% |
159,224
-52,879
| -25% | -$25.8M |
|
102
Verizon
VZ
$197B
| $72.3M | 0.24% |
1,943,995
+128,121
| +7% | +$4.74M |
|
103
Starbucks
SBUX
$119B
| $70.2M | 0.23% |
708,923
+17,105
| +2% | +$1.78M |
|
104
UBS Group
UBS
$170B
| $69.3M | 0.23% |
3,417,156
-1,770,948
| -34% | -$35.6M |
|
105
3M
MMM
$91.8B
| $67.8M | 0.23% |
809,745
-197,280
| -20% | -$16.8M |
|
|
ALTR
106
DELISTED
Altair Engineering Inc
ALTR
| $66.8M | 0.22% |
881,136
-5,397
| -0.6% | -$386K |
|
|
107
Pfizer
PFE
$143B
| $66.4M | 0.22% |
1,809,607
-1,482,990
| -45% | -$57.7M |
|
108
AvalonBay Communities
AVB
$27.5B
| $65.9M | 0.22% |
348,286
-15,255
| -4% | -$2.72M |
|
109
Cognex
CGNX
$9.62B
| $65.9M | 0.22% |
1,176,342
-104,071
| -8% | -$5.38M |
|
110
Berkshire Hathaway Class B
BRK.B
$1.1T
| $65.8M | 0.22% |
192,875
-392
| -0.2% | -$128K |
|
111
GXO Logistics
GXO
$5.93B
| $65.7M | 0.22% |
1,045,930
+277,308
| +36% | +$15.6M |
|
112
Synopsys
SNPS
$71.6B
| $65.3M | 0.22% |
150,086
-46,555
| -24% | -$18.8M |
|
113
Xylem
XYL
$28.5B
| $64.6M | 0.21% |
573,925
+211,197
| +58% | +$22.3M |
|
114
KLA
KLAC
$222B
| $63.6M | 0.21% |
1,311,700
+77,980
| +6% | +$3.26M |
|
115
Zimmer Biomet
ZBH
$18.8B
| $63.3M | 0.21% |
434,822
+109,606
| +34% | +$14.9M |
|
116
Lam Research
LRCX
$316B
| $62.7M | 0.21% |
975,450
-145,240
| -13% | -$8.19M |
|
117
Idexx Laboratories
IDXX
$44.9B
| $61.1M | 0.2% |
121,658
-12,334
| -9% | -$5.91M |
|
118
Moderna
MRNA
$21.6B
| $59.9M | 0.2% |
493,041
+113,540
| +30% | +$15.1M |
|
119
CVS Health
CVS
$135B
| $59.9M | 0.2% |
865,861
-165,646
| -16% | -$11.8M |
|
120
Intercontinental Exchange
ICE
$87.2B
| $59.6M | 0.2% |
527,232
-14,962
| -3% | -$1.62M |
|
121
Meta Platforms (Facebook)
META
$1.49T
| $58.7M | 0.2% |
204,682
-18,158
| -8% | -$4.48M |
|
122
PayPal
PYPL
$50.3B
| $58.4M | 0.19% |
874,998
+91,314
| +12% | +$6.23M |
|
123
Progressive
PGR
$128B
| $57.8M | 0.19% |
436,345
-26,987
| -6% | -$3.62M |
|
124
Oracle
ORCL
$339B
| $57.7M | 0.19% |
484,142
+22,456
| +5% | +$2.32M |
|
125
Planet Fitness
PLNT
$4.45B
| $57.6M | 0.19% |
854,105
+17,077
| +2% | +$1.22M |
|
Similar funds
PHAM
HFRG
EBWM
GCCM
CIA
KAM
ACM
CCA
Axa's Q2 2023 Portfolio in Review
As of Q2 2023, Axa held 1,200 positions worth $30.1B, up 3.5% from $29.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Axa withdrew a net $1.16B in Q2 2023, closing 122 positions and reducing 497 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $44.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Axa opened a new position in Lincoln Electric worth $19.9M.
- Axa's largest Q2 2023 buy was Lincoln Electric: 100,054 shares worth $19.9M.
- Axa added most to Intuit in Q2 2023, an estimated $50.1M increase.
- Axa's biggest Q2 2023 reduction was Apple, cutting an estimated $92.9M.
- Axa fully exited Vanguard S&P 500 ETF in Q2 2023, selling an estimated $44.8M.
- Axa's ten largest holdings make up 23% of its $30.1B portfolio in Q2 2023.
- Axa opened 104 new positions and closed 122 in Q2 2023.
- Axa's portfolio value rose 3.5% quarter-over-quarter to $30.1B.
Based on Axa's 13F filing for Q2 2023, filed 14 Aug 2023.